# Expand New Drugs for TB [endTB]

> **NCT03259269** · — · COMPLETED · sponsor: **Partners in Health** · enrollment: 2804 (actual)

## Conditions studied

- Tuberculosis, Multidrug-Resistant

## Interventions

- **OTHER:** This is a non-intervention observational study

## Key facts

- **NCT ID:** NCT03259269
- **Lead sponsor:** Partners in Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-01
- **Primary completion:** 2019-09-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 2804 (ACTUAL)
- **Last updated:** 2022-06-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03259269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03259269, "Expand New Drugs for TB [endTB]". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03259269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*